Related Experiment Videos
[An etiological study on fulminant viral hepatitis]
Zhonghua Nei Ke Za Zhi
|November 1, 1992
Summary
This study on viral hepatitis and liver failure found that Hepatitis B virus (HBV) and Hepatitis C virus (HCV) coinfections are common and linked to severe outcomes. Identifying viral markers is crucial for predicting patient prognosis.
Area of Science:
- Hepatology
- Virology
- Clinical Medicine
Context:
- Viral hepatitis is a significant cause of hepatic failure globally.
- Co-infections with multiple hepatitis viruses complicate disease presentation and outcomes.
- Accurate identification of viral markers is essential for patient management.
Purpose:
- To investigate the prevalence of various viral markers in patients with viral hepatitis and hepatic failure.
- To correlate the presence of specific viral markers and co-infections with clinical severity and mortality.
- To assess the impact of viral co-infections on disease progression and outcomes.
Summary:
- In 79 viral hepatitis cases with hepatic failure, anti-HAV IgM was found in 10.12%, HBsAg or anti-HBc IgM in 96.20%, and anti-HCV antibodies in 51.89%.
- Hepatitis B virus (HBV)/Hepatitis C virus (HCV) co-infections were frequent (35/41 HCV-positive cases), associated with increased critical illness and mortality.
- Hepatic failure without HBV replicative markers correlated with a high incidence of hepatic coma and poor prognosis.
Impact:
- This research highlights the critical role of viral marker detection in stratifying risk and predicting outcomes in hepatic failure.
- Findings emphasize the need for comprehensive viral screening in patients with severe liver disease.
- Understanding co-infection dynamics can inform targeted therapeutic strategies and improve patient survival rates.